Curative Ventures V LLC

Q4 2021 13F Holdings Report, Stock Holdings

Signature - Title
Bronson Crouch - Manager of CV-Immetacyte Manager LP
Location
Dallas, TX
Holdings as of
31 Dec 2021
Value $
$0
Num holdings
1
Filing time
14 Feb 2022, 10:29:22 UTC
Form type
13F-HR
Description
All US holdings of this investor are reported in this report. Top holdings included .
Next filing
Q1 2022 - 13 May 2022
SEC
View on sec.gov
Our algorithm has found invalid data in this filing
Sym Weight Trade Impact Company Class Share Change Activity Value Change $ Value $ * Price $ Shares Principal
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Bronson Crouch Manager of CV-Immetacyte Manager LP Dallas, Texas 13 Feb 2022